Clinical Scorecard: Low-Dose PFAS Exposure Alters Cellular Metabolism
At a Glance
| Category | Detail |
|---|---|
| Condition | Low-dose exposure to per- and polyfluoroalkyl substances (PFAS) |
| Key Mechanisms | Alterations in oxidative stress pathways and lipid metabolism despite minimal intracellular accumulation |
| Target Population | Human epithelial cells (hTERT RPE-1) |
| Care Setting | In vitro cell culture model |
Key Highlights
- PFAS exposure alters cellular metabolism even with low intracellular accumulation
- PFOA remained below detection limits; PFOS levels stabilized at 0.40 ng/mg of cellular protein
- Molecular responses include changes in oxidative stress pathways and lipid composition
- Chronic PFAS exposure triggers adaptive cellular responses
- PFAS toxicity may arise from interactions with cellular membranes rather than accumulation
Guideline-Based Recommendations
Diagnosis
- Monitor exposure levels to PFAS in relevant populations
Management
- Consider potential cellular responses to low-dose PFAS exposure in risk assessments
Monitoring & Follow-up
- Utilize multi-omic analyses to evaluate cellular responses to PFAS exposure
Risks
- Assess risks associated with prolonged exposure to PFAS despite low accumulation
Patient & Prescribing Data
Individuals exposed to PFAS in environmental settings
Focus on understanding cellular responses rather than solely on accumulation levels
Clinical Best Practices
- Incorporate multi-omic approaches in research on PFAS exposure
- Evaluate the implications of oxidative stress and lipid metabolism changes in health assessments
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
